Lumos Diagnostics Signs Exclusive Romania Distribution Agreement for Rapid Respiratory Infection Test; Shares Up 10%

MT Newswires Live
07/30

Lumos Diagnostics Holdings (ASX:LDX) has entered into an exclusive distribution agreement with Romania-based Alpha Medical to commercialize its FebriDx rapid point-of-care diagnostic test across Romania, according to a Thursday filing with the Australian bourse.

Alpha Medical has already placed an initial stocking order to ensure the products are available for immediate supply, per the filing.

The partnership expands the company's European distribution network, building on agreements with Henry Schein and Interlux to broaden access to FebriDx through experienced regional partners, the filing added.

The company's shares rose around 10% in recent Thursday trade.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10